EGFR testing patterns and survival in stage I–III non-small cell lung cancer (NSCLC): Analysis using the CancerLinQ Discovery® (CLQD) database

66P

  • Potter, D.
  • Sun, P.
  • Li, J.
  • Luo, L.
  • Taylor, A.

  • 1CancerLinQ, American Society of Clinical Oncology, Alexandria, VA, USA

    2AstraZeneca, Cambridge, UK

    3AstraZeneca, Gaithersburg, MD, USA

Journal of Thoracic Oncology 16(4):p S731, April 2021. | DOI: 10.1016/S1556-0864(21)01908-0
Copyright © 2021 by the International Association for the Study of Lung Cancer
View full text|Download PDF